Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
Pharmacoepidemiology and Drug Safety
|
January 9, 2020
A rapid monitoring plan following a shift in coverage from brand name to biosimilar drugs for rheumatoid arthritis in British Columbia
Colin R Dormuth, Anat Fisher, Greg Carney
Pharmacoeconomics
|
October 21, 2005
Using policy simulation to predict drug plan expenditure when planning reimbursement changes
Colin R Dormuth, Sean Burnett, Sebastian Schneeweiss
Gastroenterology Research and Practice
|
March 13, 2023
Monitoring a Mandatory Nonmedical Switching Policy from Originator to Biosimilar Infliximab in Patients with Inflammatory Bowel Diseases: A Population-Based Cohort Study
Anat Fisher, Jason D Kim, Colin R Dormuth
CMAJ Open
|
August 1, 2023
Trends in antihypertensive drug utilization in British Columbia, 2004-2019: a descriptive study
Jason D Kim, Anat Fisher, Colin R Dormuth
CMAJ Open
|
February 16, 2022
Mandatory nonmedical switching from originator to biosimilar infliximab in patients with inflammatory arthritis and psoriasis in British Columbia: a cohort study
Anat Fisher, Jason D Kim, Colin R Dormuth
Pharmacoepidemiology and Drug Safety
|
May 29, 2020
Rapid monitoring of health services utilization following a shift in coverage from brand name to biosimilar drugs in British Columbia-An interim report
Anat Fisher, Jason D Kim, Colin R Dormuth
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 15, 2011
Trends in health care utilization in British Columbia following public coverage for tiotropium
Colin R Dormuth, Richard L Morrow, Greg Carney
Contemporary Clinical Trials
|
February 3, 2016
Likelihood ratio meta-analysis: New motivation and approach for an old method
Colin R Dormuth, Kristian B Filion, Robert W Platt
Drugs & Aging
|
February 1, 2017
Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching
Anat Fisher, Greg Carney, Ken Bassett, et al.
BMC Medical Research Methodology
|
February 20, 2016
Head to head comparison of the propensity score and the high-dimensional propensity score matching methods
Jason R Guertin, Elham Rahme, Colin R Dormuth, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
Pharmacoepidemiology and Drug Safety
|
January 9, 2020
A rapid monitoring plan following a shift in coverage from brand name to biosimilar drugs for rheumatoid arthritis in British Columbia
Colin R Dormuth, Anat Fisher, Greg Carney
Pharmacoeconomics
|
October 21, 2005
Using policy simulation to predict drug plan expenditure when planning reimbursement changes
Colin R Dormuth, Sean Burnett, Sebastian Schneeweiss
Gastroenterology Research and Practice
|
March 13, 2023
Monitoring a Mandatory Nonmedical Switching Policy from Originator to Biosimilar Infliximab in Patients with Inflammatory Bowel Diseases: A Population-Based Cohort Study
Anat Fisher, Jason D Kim, Colin R Dormuth
CMAJ Open
|
August 1, 2023
Trends in antihypertensive drug utilization in British Columbia, 2004-2019: a descriptive study
Jason D Kim, Anat Fisher, Colin R Dormuth
CMAJ Open
|
February 16, 2022
Mandatory nonmedical switching from originator to biosimilar infliximab in patients with inflammatory arthritis and psoriasis in British Columbia: a cohort study
Anat Fisher, Jason D Kim, Colin R Dormuth
Pharmacoepidemiology and Drug Safety
|
May 29, 2020
Rapid monitoring of health services utilization following a shift in coverage from brand name to biosimilar drugs in British Columbia-An interim report
Anat Fisher, Jason D Kim, Colin R Dormuth
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 15, 2011
Trends in health care utilization in British Columbia following public coverage for tiotropium
Colin R Dormuth, Richard L Morrow, Greg Carney
Contemporary Clinical Trials
|
February 3, 2016
Likelihood ratio meta-analysis: New motivation and approach for an old method
Colin R Dormuth, Kristian B Filion, Robert W Platt
Drugs & Aging
|
February 1, 2017
Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching
Anat Fisher, Greg Carney, Ken Bassett, et al.
BMC Medical Research Methodology
|
February 20, 2016
Head to head comparison of the propensity score and the high-dimensional propensity score matching methods
Jason R Guertin, Elham Rahme, Colin R Dormuth, et al.
Page
of 9